• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab.

作者信息

Bruchfeld Annette, Kronbichler Andreas, Alberici Federico, Fervenza Fernando C, Jayne David R W, Segelmark Mårten, Tesar Vladimir, Szpirt Wladimir M

机构信息

Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.

Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet, Stockholm, Sweden.

出版信息

Nephrol Dial Transplant. 2021 Aug 27;36(9):1758-1760. doi: 10.1093/ndt/gfab174.

DOI:10.1093/ndt/gfab174
PMID:33944946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8136000/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f049/8396400/4e4463b08879/gfab174f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f049/8396400/4e4463b08879/gfab174f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f049/8396400/4e4463b08879/gfab174f1.jpg

相似文献

1
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab.2019冠状病毒病与抗中性粒细胞胞浆抗体相关性血管炎：疫苗接种准备及利妥昔单抗使用建议
Nephrol Dial Transplant. 2021 Aug 27;36(9):1758-1760. doi: 10.1093/ndt/gfab174.
2
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎中的轻度新型冠状病毒肺炎
Ann Rheum Dis. 2021 Jun;80(6):e99. doi: 10.1136/annrheumdis-2020-218246. Epub 2020 Aug 7.
3
Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.利妥昔单抗治疗的抗中性粒细胞胞浆抗体相关性血管炎患者对新冠病毒加强疫苗的抗体反应
Kidney Int. 2022 Feb;101(2):414-415. doi: 10.1016/j.kint.2021.11.012. Epub 2021 Nov 22.
4
Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti-neutrophil cytoplasmic antibody vasculitis.利妥昔单抗对抗中性粒细胞胞浆抗体血管炎患者针对新冠病毒加强疫苗的体液反应及抗体动力学的影响
Kidney Int. 2021 Nov;100(5):1124-1127. doi: 10.1016/j.kint.2021.08.020. Epub 2021 Sep 7.
5
The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Fcγ 受体和细胞色素 P450 酶的遗传关联与抗中性粒细胞胞质抗体相关性血管炎患者对利妥昔单抗或环磷酰胺治疗反应的相关性。
Arthritis Rheumatol. 2017 Jan;69(1):169-175. doi: 10.1002/art.39822.
6
Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission.抗中性粒细胞胞质抗体相关性垂体血管炎肾缓解后无抗中性粒细胞胞质抗体升高的异位复发。
Intern Med. 2020 Dec 15;59(24):3187-3193. doi: 10.2169/internalmedicine.4731-20. Epub 2020 Aug 12.
7
Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.血清钙卫蛋白（S100A8/A9）水平与蛋白酶 3 抗中性粒细胞胞质抗体相关性血管炎疾病复发的相关性。
Arthritis Rheumatol. 2017 Jan;69(1):185-193. doi: 10.1002/art.39814.
8
Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.影响抗中性粒细胞胞浆抗体（针对蛋白酶 3）连续检测临床效用的因素。
Arthritis Rheumatol. 2016 Jul;68(7):1700-10. doi: 10.1002/art.39637.
9
Rituximab prescription patterns and efficacy in the induction treatment of ANCA-Associated Vasculitis in a Belgian multicenter cohort.利妥昔单抗在比利时多中心队列中诱导治疗抗中性粒细胞胞浆抗体相关性血管炎的处方模式和疗效。
Acta Clin Belg. 2020 Jun;75(3):163-169. doi: 10.1080/17843286.2019.1578041. Epub 2019 Feb 15.
10
Vasculitis: Rituximab: effective in ANCA-associated vasculitis?血管炎：利妥昔单抗：对抗中性粒细胞胞浆抗体相关血管炎有效吗？
Nat Rev Nephrol. 2011 Jan;7(1):6-8. doi: 10.1038/nrneph.2010.167.

引用本文的文献

1
Top ten tips in managing ANCA vasculitis.抗中性粒细胞胞浆抗体相关性血管炎的十大管理要点。
Clin Kidney J. 2024 Nov 30;18(2):sfae389. doi: 10.1093/ckj/sfae389. eCollection 2025 Feb.
2
Two Decades Rituximab Therapy in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎二十年
Curr Drug Targets. 2025;26(2):73-87. doi: 10.2174/0113894501323529240910015912.
3
Analysis of T-cell and Humoral Immune Response to SARS-CoV-2 Antigens in Rituximab-Treated Patients with Rheumatoid Arthritis Vaccinated with Combined Vector Vaccine Gam-COVID-Vac.
分析利妥昔单抗治疗的类风湿关节炎患者接种联合载体疫苗 Gam-COVID-Vac 后对 SARS-CoV-2 抗原的细胞和体液免疫反应。
Bull Exp Biol Med. 2024 Apr;176(6):786-790. doi: 10.1007/s10517-024-06109-9. Epub 2024 Jun 19.
4
New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome.新型冠状病毒感染及疫苗接种后新发系统性血管炎：触发因素、表型及结局。
Clin Rheumatol. 2023 Oct;42(10):2761-2775. doi: 10.1007/s10067-023-06694-6. Epub 2023 Jul 8.
5
Anti-SARS-CoV-2 IgG antibody titer after BNT162b2 mRNA COVID-19 vaccination in Japanese patients who underwent renal replacement therapy, hemodialysis, peritoneal dialysis, and kidney transplantation.接受肾脏替代治疗、血液透析、腹膜透析和肾移植的日本患者接种 BNT162b2 mRNA COVID-19 疫苗后的抗 SARS-CoV-2 IgG 抗体滴度。
Clin Exp Nephrol. 2023 Aug;27(8):660-671. doi: 10.1007/s10157-023-02348-8. Epub 2023 Apr 24.
6
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients.肾移植受者的免疫抑制与新冠病毒感染
Transplant Direct. 2022 Feb 10;8(3):e1292. doi: 10.1097/TXD.0000000000001292. eCollection 2022 Mar.
7
SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.抗中性粒细胞胞浆抗体相关血管炎患者对SARS-CoV-2疫苗的反应
Kidney Int Rep. 2022 Mar;7(3):629-632. doi: 10.1016/j.ekir.2021.12.004. Epub 2021 Dec 11.
8
COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus.COVID 疫苗接种在接受利妥昔单抗治疗的患者中：来自伊朗的两例病例报告及当前知识的综述，特别关注天疱疮。
Dermatol Ther. 2022 Jan;35(1):e15216. doi: 10.1111/dth.15216. Epub 2021 Dec 1.
9
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum.COVID-19 大流行与抗中性粒细胞胞浆抗体相关性血管炎——EUVAS 会议和 EUVAS 教育论坛的报告。
Autoimmun Rev. 2021 Dec;20(12):102986. doi: 10.1016/j.autrev.2021.102986. Epub 2021 Oct 28.
10
Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey.管理 COVID-19 大流行期间的抗中性粒细胞胞质抗体相关性血管炎：一项在线调查的结果。
Rheumatol Int. 2021 Nov;41(11):1941-1947. doi: 10.1007/s00296-021-04975-4. Epub 2021 Aug 24.